In most cases of acromegaly, this excessive growth hormone production stems from a noncancerous tumor in the pituitary gland. However, in rarer instances, the disease can be triggered by tumors ...

When Ray Kohn started feeling pain in his knees and elbows in 2015, he attributed it to his work as a stunt driver and ...

The novel consensus statement highlights current analytical pitfalls and the need to optimize disease control in acromegaly. Acromegaly is a serious endocrine disease associated with increased ...

Recent research has focused on understanding the safety of pregnancy in women with acromegaly, evaluating outcomes, and determining the impact of disease activity on pregnancy management.

The following is a summary of “Paradoxical GH response at OGTT does not predict Pasireotide efficacy but matters for glucose metabolism,” published in the January 2025 issue of Endocrinology by Occhi ...

A machine learning model was more accurate than 12 experienced endocrinologists in identifying adults with acromegaly based on voice recordings, according to findings published in The Journal of ...

Somatostatin analogues are clinically used for the treatment of acromegaly and have the benefit of both reduction of tumor size and hormonal control of this disease. Because pituitary corticotroph ...

Somatuline is used for the long-term treatment of acromegaly, a rare disease caused by excess growth hormone production as a result of a tumour in the pituitary gland, in patients who cannot be ...

In about 80% of families the gene causing the disease is unknown. The pituitary tumour types occurring in these families are most commonly growth hormone-secreting adenomas (causing acromegaly or ...